Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperdal Consta in Psychotic Disorders with Incomplete Adherence
NCT00215579Phase 4Completed
- Sponsor
- Duke University
- Start
- Apr 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by Duke University. Started Apr 2004; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00215579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215579.